Investor relations

We use the innovative power in combining material science and pharma,
revolutionizing drug delivery and giving patients a better and safer everyday life

We create new and innovative products with shorter time to market and mitigated risk.
We make this possible by combining material science & pharmaceutical development and by using established and approved active substances.

Latest Reports

Financial Calendar

August 20 2021
Interim Report Q2 2021
November 19 2021
Interim Report Q3 2021

IR contact


Recieve press releases and reports via email.